IDH1 and cancer: This effect could be reversed by IDH mutation independent of D-2HG production, although D-2HG is considered as an oncometabolite to regulate DNA/histone methylation, hypoxia signaling, and DNA repair, affecting the oncogenesis of IDH-mutated cancers [43].